Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.2122
-0.0091 (-4.11%)
At close: May 1, 2026, 4:00 PM EDT
0.2079
-0.0043 (-2.03%)
After-hours: May 1, 2026, 7:59 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $1.07 million as of May 1, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
1.07M
Enterprise Value
5.24M
1-Year Change
-99.99%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $1.07M, a decrease of -99.70%. That is a compound annual growth rate of -76.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 1.07M | -92.48% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
| Apr 11, 2022 | 349.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Virax Biolabs Group | 2.63M |
| Scinai Immunotherapeutics | 2.46M |
| Calidi Biotherapeutics | 2.39M |
| Bone Biologics | 2.36M |
| Adial Pharmaceuticals | 2.21M |
| Propanc Biopharma | 2.16M |
| Silexion Therapeutics | 1.99M |
| Biodexa Pharmaceuticals | 1.96M |